|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 441.16 USD | -0.70% |
|
-0.24% | -2.32% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology | 7.57B | 8.93B | 9.87B | 11.02B | 12B | |||||
Total Assets | 13.43B | 18.15B | 22.73B | 22.53B | 25.64B | |||||
Interest Expense | -61.5M | -54.8M | -44.1M | -30.6M | -13.3M | |||||
Income Tax Expense | 388M | 910M | 760M | 784M | 690M | |||||
CAPEX | -235M | -205M | -200M | -298M | -438M | |||||
EBT | 2.73B | 4.23B | 4.38B | 248M | 4.64B | |||||
D&A | 126M | 148M | 181M | 182M | 179M | |||||
Operating Income | 2.78B | 4.31B | 3.83B | -233M | 4.17B | |||||
Net Income | 2.34B | 3.32B | 3.62B | -536M | 3.95B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 5.29B | 5.7B | 6.04B | 6.68B | 7.55B | |||||
Total Assets | 1.35B | 1.37B | 1.36B | 2.39B | 2.89B | |||||
Total Assets | 60.9M | 75.7M | 77.3M | 177M | 168M | |||||
Europe | 1.97B | 2.71B | 3.11B | 3.45B | 3.46B | |||||
Other | 313M | 526M | 720M | 881M | 992M | |||||
Total Assets | 15.4M | 14.6M | 15.9M | 15.6M | 27M |
- Stock Market
- Equities
- VRTX Stock
- Financials Vertex Pharmaceuticals Incorporated
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition